Population | Ad2 NAb Titers >200 | Â | Â | Ad5 NAb Titers >200 | Â | Â |
---|---|---|---|---|---|---|
No. (%a, %b) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | No. (%, %) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
Overall | 123 (44.89) | Â | Â | 74 (27.01) | Â | Â |
Age | Â | Â | Â | Â | Â | Â |
0-6 mo | 25 (50.00, 20.33) | 1.00 | Â | 20 (40.00, 27.03) | 1.00 | Â |
7-12 mo | 2 (5.41, 1.63) | 0.06 (0.01, 0.26) | 0.07 (0.02, 0.30) | 4 (10.81, 5.40) | 0.18 (0.06, 0.59) | 0.33 (0.11, 0.96) |
13-24 mo | 21 (50.00, 17.07) | 1.00 (0.44, 2.27) | 1.23 (0.64, 2.35) | 8 (19.05, 10.81) | 0.35 (0.14, 0.92) | 0.64 (0.28, 1.44) |
3-6 yr | 45 (46.39, 36.58) | 0.87 (0.44, 1.71) | 1.06 (0.67, 1.69) | 26 (26.80, 35.14) | 0.55 (0.27, 1.13) | 0.99 (0.59, 1.67) |
7-12 yr | 30 (62.50, 24.39) | 1.67 (0.74, 3.73) | 2.05 (1.09, 3. 85) | 16 (33.33, 21.62) | 0.75 (0.33, 1.71) | 1.35 (0.70, 2.61) |
Sex | Â | Â | Â | Â | Â | Â |
Male | 58 (39.73, 47.15) | 1.00 | Â | 40 (27.40, 54.05) | 1.00 | Â |
Female | 65 (50.78, 52.85) | 1.56 (0.97, 2.53) | Â | 34 (26.56, 45.95) | 0.96 (0.56, 1.64) |